Today’s
Managing Health Care Costs Indicator is $1.1 Billion
Clay Christensen, the Harvard Business School professor who
is the father of “disruptive
innovation” has teamed up with Jeffrey Flier, the dean of Harvard Medical
School, to
declare that Accountable Care Organizations are unlikely to succeed because
the “ACO concept is based on assumptions about personal and economic behavior –
by doctors, patients and others- that aren’t realistic.” (Wall Street Journal, 2/19/13)
Specifically, they declare that ACOs are unlikely to change
ingrained doctor behavior – and unlikely to increase patient engagement. They believe that health care reform needs
to offer steerage to the most cost-effective facilities – much as the Medicare
Advantage plans currently offer. They
also say that ACOs will be unable to impact the cost or quality of care for
patients who spend substantial time in different geographies (such as the
snowbirds who go to FL or AZ for the winter), or who refuse to follow their
physicians’ recommendations. They point out that the total savings estimated
from ACOs, for all the hype around these new organizations, is only $1.1
billion over five years, less than 0.05%
of the Medicare budget.
One further concern about ACOs that the authors don’t
highlight is the requirement for increased provider integration, which can lead
to higher negotiated prices from employer-sponsored health plans, even if the ACOs
offer cost savings to Medicare.
I believe that overall the Affordable Care Act can promote
disruptive innovation. Here’s a link
to a JGIM commentary by Eyal Zimlichman and me on that topic. Even Accountable Care Organizations can
promote disruptive innovation to the extent that decision-makers in medical
care choices are often physicians, and the move away from fee for service
payment can provide openings for technologies that really save money, as
opposed to the current approach of preferring technologies that are “accretive”
in that they are simply layered on top of all the care and technology we already
offer.
But the Christensen commentary is an important warning that many
structures in health care reform could have unintended consequences, and could
provide far fewer cost savings than advertised. We have to study as we implement, and change
as we learn.
3 comments:
Do you think comparative effectiveness has potential to limit accretive innovation?
Basically, Christensen's argument is that ACOs will not work because doctors can't change referral patterns. But the AQC has shown that referral patterns can dramatically change within just a year or two.
Comparative effectiveness can help us make higher value purchasing decisions. I think ACOs that bear financial responsibility will resist accretive innovations.
Agree that referral patterns can change if the incentives and the infrastructure is right.
Is it possible that accountable care organizations (ACOs) will create an uptick in medical malpractice claims? http://www.healthcaretownhall.com/?p=6245
Post a Comment